天齊鋰業(002466.SZ):控股股東補充質押360萬股
格隆匯4月16日丨天齊鋰業(002466.SZ)公佈,2020年4月16日,公司收到控股股東成都天齊實業(集團)有限公司(“天齊集團”)通知,天齊集團將其持有的360萬股公司股份補充質押給光大銀行成都八寶街支行。
天齊集團未來半年內到期的質押股份累計數量21105萬股,佔其所持股份比例39.64%,佔公司總股本比例14.29%,對應融資餘額16.556億元;未來一年內到期的質押股份累計數量34,969萬股,佔其所持股份比例65.68%,佔公司總股本比例23.67%,對應融資餘額32.716億元。天齊集團還款資金來源主要來自於天齊集團自有及自籌資金,其具有一定的資金償還能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.